Blogs

US FDA Announces Increased Efforts to Ensure Proper Oversight of Stem Cell Therapies

  

August 28

US FDA Commissioner Scott Gottlieb, M.D., issues statement on the FDA's new policy steps and enforcement efforts to ensure proper oversight of stem cell therapies and regenerative medicine. Read the News Release »

US FDA warns US Stem Cell Clinic of significant deviations. Read the News Release »

August 24

US FDA issues Warning Letter to US Stem Cell Clinic, LLC Read the Warning Letter »

0 comments
1 view

Permalink